Iridoid Scaffolds as Multitarget Antidiabetic Agents: Chemistry, Biosynthesis, Mechanisms, Structure–Activity Relationship, and Molecular Targets in Type 2 Diabetes Therapy
Type 2 diabetes mellitus (T2DM) is a complex metabolic disorder characterized by chronic hyperglycemia, impaired insulin signalling, and progressive metabolic dysfunction, posing a major global health challenge. Natural products remain valuable sources of bioactive scaffolds for antidiabetic drug discovery, with irid...